🔎 Trials Near Me

Home › Follicular Lymphoma › Pennsylvania › Pittsburgh

Follicular Lymphoma clinical trials in Pittsburgh, PA

8 studies for Follicular Lymphoma are looking for participants at sites in and around Pittsburgh (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer

RecruitingPhase 3
  • Allegheny General Hospital, Pittsburgh
  • UPMC Hillman Cancer Center, Pittsburgh
  • UPMC-Shadyside Hospital, Pittsburgh
  • and 2 more
Ages 12 and older · All sexes · Updated Oct 2, 2026 · NCT07215910

A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients

RecruitingPhase 3
  • Research Site, Pittsburgh
Ages 18 to 130 · All sexes · Updated Sep 21, 2026 · NCT06549595

Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL

RecruitingPhase 2
  • Research Site, Pittsburgh
Ages 18 and older · All sexes · Updated Sep 11, 2026 · NCT06526793

Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma

RecruitingPhase 1
  • UPMC Hillman Cancer Center, Pittsburgh
Ages 18 and older · All sexes · Updated Sep 2, 2026 · NCT06860594

SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)

RecruitingPhase 3
  • UPMC Hillman Cancer Center, Pittsburgh
Ages 18 and older · All sexes · Updated Aug 28, 2026 · NCT05303519

Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

RecruitingPhase 1/2
  • West Penn Hospital, Pittsburgh
Ages 18 and older · All sexes · Updated Aug 25, 2026 · NCT05826535

Loncastuximab Tesirine in Combination With Rituximab in Patients With Relapsed or Refractory Follicular Lymphoma

RecruitingPhase 2
  • Allegheny Health Network, Pittsburgh
Ages 18 and older · All sexes · Updated Mar 23, 2026 · NCT04998669

Local Manufacture of CAR T-Cell Products for the Treatment of B-Cell Lymphoma and B-Acute Lymphoblastic Leukemia

RecruitingPhase 2
  • AHN Cancer Institute - West Penn Hospital, Pittsburgh
Ages 18 to 79 · All sexes · Updated Jan 13, 2025 · NCT05281809

Follicular Lymphoma trials in other cities

Other studies in Pittsburgh

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.